Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
Foresight Diagnostics’ $58.75 Million Series B Financing Round
EpiBiologics’ $50 Million Series A Financing
Wilson Sonsini advised EpiBiologics on the deal. EpiBiologics, a biotechnology company building a next-generation antibody-based protein degradation platform for membrane and extracellular drug targets, launched with...